WOAG
WITHDRAWAL OF ATTORNEY GRANTED
12/18/2024
Back to search
Official data from USPTO
AKRON PHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
04/03/2026
Classification
Registered
Trademark type
Combined
Nice classes
5
Filing date
06/29/2023
Registration date
12/17/2024
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/17/2024
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
05/06/2023
First use in commerce
05/06/2023
Drawing code
3
Owner type
16
Owner location
RICHMOND HILL, NY, US
Examiner
FENNESSY, EDWARD JOHN
Law office
L10
Current location
TMEG LAW OFFICE 101
Mark description
The mark consists of the stylied wording "Akron Pharma", the letter "o" shaped as a chemical flask with some liquid inside it.
Holders and representatives
Holders
AKRON GENERICS LLC
AKRON GENERICS LLC
Representatives
AKRON GENERICS LLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Antibiotics; Liniments; Capsules made from vegetablesstarchgelatinsold empty for pharmaceuticals; Drug delivery agents in the form of dissolvable filmscoatings for tabletsthat facilitate the delivery of pharmaceutical preparations; Hemorrhoid preparations; Hydrocortisone cream; Hydrogen peroxide for medical use; Isopropyl alcohol for medical use; Mentholated ointment for medical use; Multipurpose medicated antibiotic creamanalgesic balm and mentholated salve; Preparation for the relief of pain; Prescription and non-prescription medicinespillstabletscapsulescapletsliquid dropssachets and pharmaceutical preparations for the treatment of cardiovascular disorders
Publications
History of USPTO decisions and trademark events.
29 publications found
WOAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
12/18/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/17/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
12/17/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/15/2024
PUBO
PUBLISHED FOR OPPOSITION
10/15/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/25/2024
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
09/18/2024
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
08/10/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/07/2024
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
08/01/2024
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
08/01/2024
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
07/25/2024
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
06/18/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/30/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/23/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/23/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/23/2024
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
05/14/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/14/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/14/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/14/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/14/2024
GNRT
NON-FINAL ACTION E-MAILED
03/14/2024
CNRT
NON-FINAL ACTION WRITTEN
03/14/2024
DOCK
ASSIGNED TO EXAMINER
03/13/2024
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
08/02/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/01/2023
NWAP
NEW APPLICATION ENTERED
07/03/2023
Continuous trademark protection
Get notified about every new filing that threatens AKRON PHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.